2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline

C176H251F2N35O2S2 — CID 160846442

IUPAC2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline
SMILESCC(C)(C)Nc1ccc2nc(NCc3ccccc3)sc2c1.CC(C)(C)Nc1ccc2nccn2c1.CC(C)(C)Nc1ccc2ncn(-c3ccccc3)c2c1.CC(C)(C)Nc1ccc2ncn(-c3ccccc3C(N)=O)c2c1.CC(C)(C)Nc1cccc(C2CCNCC2)c1.CCn1cc(NC(C)(C)C)cn1.CN(C)CCNc1nc2ccc(NC(C)(C)C)cc2s1.CN1CCC(c2cc(NC(C)(C)C)ccc2F)CC1.CN1CCC(c2cccc(NC(C)(C)C)c2)CC1.CN1CCN(c2cc(NC(C)(C)C)ccc2F)CC1.COc1n[nH]c2ccc(NC(C)(C)C)cc12.Cn1ccnc1-c1cccc(NC(C)(C)C)c1
InChIInChI=1S/C18H20N4O.C18H21N3S.C17H19N3.C16H25FN2.C16H26N2.C15H24FN3.C15H24N4S.C15H24N2.C14H19N3.C12H17N3O.C11H15N3.C9H17N3/c1-18(2,3)21-12-8-9-14-16(10-12)22(11-20-14)15-7-5-4-6-13(15)17(19)23;1-18(2,3)21-14-9-10-15-16(11-14)22-17(20-15)19-12-13-7-5-4-6-8-13;1-17(2,3)19-13-9-10-15-16(11-13)20(12-18-15)14-7-5-4-6-8-14;1-16(2,3)18-13-5-6-15(17)14(11-13)12-7-9-19(4)10-8-12;1-16(2,3)17-15-7-5-6-14(12-15)13-8-10-18(4)11-9-13;1-15(2,3)17-12-5-6-13(16)14(11-12)19-9-7-18(4)8-10-19;1-15(2,3)18-11-6-7-12-13(10-11)20-14(17-12)16-8-9-19(4)5;1-15(2,3)17-14-6-4-5-13(11-14)12-7-9-16-10-8-12;1-14(2,3)16-12-7-5-6-11(10-12)13-15-8-9-17(13)4;1-12(2,3)13-8-5-6-10-9(7-8)11(16-4)15-14-10;1-11(2,3)13-9-4-5-10-12-6-7-14(10)8-9;1-5-12-7-8(6-10-12)11-9(2,3)4/h4-11,21H,1-3H3,(H2,19,23);4-11,21H,12H2,1-3H3,(H,19,20);4-12,19H,1-3H3;5-6,11-12,18H,7-10H2,1-4H3;5-7,12-13,17H,8-11H2,1-4H3;5-6,11,17H,7-10H2,1-4H3;6-7,10,18H,8-9H2,1-5H3,(H,16,17);4-6,11-12,16-17H,7-10H2,1-3H3;5-10,16H,1-4H3;5-7,13H,1-4H3,(H,14,15);4-8,13H,1-3H3;6-7,11H,5H2,1-4H3
InChIKeySIRYBHDXTKVNLY-UHFFFAOYSA-N
MW2991.32 g/mol
LogP40.61
Rot. Bonds29

About 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline

2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline (PubChem CID 160846442) has the molecular formula C176H251F2N35O2S2 and a molecular weight of 2991.32 g/mol. Its IUPAC name is 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline.

Molecular Properties

Compound Name2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline
PubChem CID160846442
Molecular FormulaC176H251F2N35O2S2
Molecular Weight2991.32 g/mol
Exact Mass2989.00
IUPAC Name2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline
SMILESCC(C)(C)Nc1ccc2nc(NCc3ccccc3)sc2c1.CC(C)(C)Nc1ccc2nccn2c1.CC(C)(C)Nc1ccc2ncn(-c3ccccc3)c2c1.CC(C)(C)Nc1ccc2ncn(-c3ccccc3C(N)=O)c2c1.CC(C)(C)Nc1cccc(C2CCNCC2)c1.CCn1cc(NC(C)(C)C)cn1.CN(C)CCNc1nc2ccc(NC(C)(C)C)cc2s1.CN1CCC(c2cc(NC(C)(C)C)ccc2F)CC1.CN1CCC(c2cccc(NC(C)(C)C)c2)CC1.CN1CCN(c2cc(NC(C)(C)C)ccc2F)CC1.COc1n[nH]c2ccc(NC(C)(C)C)cc12.Cn1ccnc1-c1cccc(NC(C)(C)C)c1
InChIInChI=1S/C18H20N4O.C18H21N3S.C17H19N3.C16H25FN2.C16H26N2.C15H24FN3.C15H24N4S.C15H24N2.C14H19N3.C12H17N3O.C11H15N3.C9H17N3/c1-18(2,3)21-12-8-9-14-16(10-12)22(11-20-14)15-7-5-4-6-13(15)17(19)23;1-18(2,3)21-14-9-10-15-16(11-14)22-17(20-15)19-12-13-7-5-4-6-8-13;1-17(2,3)19-13-9-10-15-16(11-13)20(12-18-15)14-7-5-4-6-8-14;1-16(2,3)18-13-5-6-15(17)14(11-13)12-7-9-19(4)10-8-12;1-16(2,3)17-15-7-5-6-14(12-15)13-8-10-18(4)11-9-13;1-15(2,3)17-12-5-6-13(16)14(11-12)19-9-7-18(4)8-10-19;1-15(2,3)18-11-6-7-12-13(10-11)20-14(17-12)16-8-9-19(4)5;1-15(2,3)17-14-6-4-5-13(11-14)12-7-9-16-10-8-12;1-14(2,3)16-12-7-5-6-11(10-12)13-15-8-9-17(13)4;1-12(2,3)13-8-5-6-10-9(7-8)11(16-4)15-14-10;1-11(2,3)13-9-4-5-10-12-6-7-14(10)8-9;1-5-12-7-8(6-10-12)11-9(2,3)4/h4-11,21H,1-3H3,(H2,19,23);4-11,21H,12H2,1-3H3,(H,19,20);4-12,19H,1-3H3;5-6,11-12,18H,7-10H2,1-4H3;5-7,12-13,17H,8-11H2,1-4H3;5-6,11,17H,7-10H2,1-4H3;6-7,10,18H,8-9H2,1-5H3,(H,16,17);4-6,11-12,16-17H,7-10H2,1-3H3;5-10,16H,1-4H3;5-7,13H,1-4H3,(H,14,15);4-8,13H,1-3H3;6-7,11H,5H2,1-4H3
InChIKeySIRYBHDXTKVNLY-UHFFFAOYSA-N
XLogP40.61
TPSA392.01 Ų
H-Bond Donors17
H-Bond Acceptors37
Rotatable Bonds29
Heavy Atoms217
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002991.32
LogP ≤ 540.61
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1037

Analyze 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline?
The IUPAC name of 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline (CID 160846442) is 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline.
What is the SMILES notation for 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline?
The canonical SMILES for 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline is CC(C)(C)Nc1ccc2nc(NCc3ccccc3)sc2c1.CC(C)(C)Nc1ccc2nccn2c1.CC(C)(C)Nc1ccc2ncn(-c3ccccc3)c2c1.CC(C)(C)Nc1ccc2ncn(-c3ccccc3C(N)=O)c2c1.CC(C)(C)Nc1cccc(C2CCNCC2)c1.CCn1cc(NC(C)(C)C)cn1.CN(C)CCNc1nc2ccc(NC(C)(C)C)cc2s1.CN1CCC(c2cc(NC(C)(C)C)ccc2F)CC1.CN1CCC(c2cccc(NC(C)(C)C)c2)CC1.CN1CCN(c2cc(NC(C)(C)C)ccc2F)CC1.COc1n[nH]c2ccc(NC(C)(C)C)cc12.Cn1ccnc1-c1cccc(NC(C)(C)C)c1.
What is the InChIKey of 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline?
The InChIKey is SIRYBHDXTKVNLY-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H20N4O.C18H21N3S.C17H19N3.C16H25FN2.C16H26N2.C15H24FN3.C15H24N4S.C15H24N2.C14H19N3.C12H17N3O.C11H15N3.C9H17N3/c1-18(2,3)21-12-8-9-14-16(10-12)22(11-20-14)15-7-5-4-6-13(15)17(19)23;1-18(2,3)21-14-9-10-15-16(11-14)22-17(20-15)19-12-13-7-5-4-6-8-13;1-17(2,3)19-13-9-10-15-16(11-13)20(12-18-15)14-7-5-4-6-8-14;1-16(2,3)18-13-5-6-15(17)14(11-13)12-7-9-19(4)10-8-12;1-16(2,3)17-15-7-5-6-14(12-15)13-8-10-18(4)11-9-13;1-15(2,3)17-12-5-6-13(16)14(11-12)19-9-7-18(4)8-10-19;1-15(2,3)18-11-6-7-12-13(10-11)20-14(17-12)16-8-9-19(4)5;1-15(2,3)17-14-6-4-5-13(11-14)12-7-9-16-10-8-12;1-14(2,3)16-12-7-5-6-11(10-12)13-15-8-9-17(13)4;1-12(2,3)13-8-5-6-10-9(7-8)11(16-4)15-14-10;1-11(2,3)13-9-4-5-10-12-6-7-14(10)8-9;1-5-12-7-8(6-10-12)11-9(2,3)4/h4-11,21H,1-3H3,(H2,19,23);4-11,21H,12H2,1-3H3,(H,19,20);4-12,19H,1-3H3;5-6,11-12,18H,7-10H2,1-4H3;5-7,12-13,17H,8-11H2,1-4H3;5-6,11,17H,7-10H2,1-4H3;6-7,10,18H,8-9H2,1-5H3,(H,16,17);4-6,11-12,16-17H,7-10H2,1-3H3;5-10,16H,1-4H3;5-7,13H,1-4H3,(H,14,15);4-8,13H,1-3H3;6-7,11H,5H2,1-4H3.
What are the key properties of 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline?
2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline has a molecular weight of 2991.32 g/mol, XLogP of 40.61, 29 rotatable bonds, 17 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 2-N-benzyl-6-N-tert-butyl-1,3-benzothiazole-2,6-diamine;2-[6-(tert-butylamino)benzimidazol-1-yl]benzamide;6-N-tert-butyl-2-N-[2-(dimethylamino)ethyl]-1,3-benzothiazole-2,6-diamine;N-tert-butyl-1-ethylpyrazol-4-amine;N-tert-butyl-4-fluoro-3-(4-methylpiperazin-1-yl)aniline;N-tert-butyl-4-fluoro-3-(1-methylpiperidin-4-yl)aniline;N-tert-butylimidazo[1,2-a]pyridin-6-amine;N-tert-butyl-3-methoxy-1H-indazol-5-amine;N-tert-butyl-3-(1-methylimidazol-2-yl)aniline;N-tert-butyl-3-(1-methylpiperidin-4-yl)aniline;N-tert-butyl-3-phenylbenzimidazol-5-amine;N-tert-butyl-3-piperidin-4-ylaniline is sourced from PubChem (CID 160846442), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).